Acute variations of cytokine levels after antipsychotic treatment in drug-naive subjects with a first-episode psychosis: A meta-analysis

被引:107
作者
Capuzzi, Enrico [1 ]
Bartoli, Francesco [1 ]
Crocamo, Cristina [1 ]
Clerici, Massimo [1 ]
Carra, Giuseppe [1 ,2 ]
机构
[1] Univ Milano Bicocca, Dept Med & Surg, Via Cadore 38, I-20900 Monza, MB, Italy
[2] UCL, Div Psychiat, 6th Floor,Maple House,149 Tottenham Court Rd, London W1T 7NF, England
关键词
Cytokines; Schizophrenia; Meta-analysis; First episode psychosis; Antipsychoticsa; INFLAMMATORY CYTOKINES; 1ST EPISODE; SCHIZOPHRENIA-PATIENTS; RISK; ACTIVATION; HYPOTHESIS; CLOZAPINE; ILLNESS; MARKERS; WEIGHT;
D O I
10.1016/j.neubiorev.2017.03.003
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Schizophrenia is likely to be associated with immunological abnormalities. However, antipsychotics may induce immunomodulatory effects, by influencing plasma cytokines. In order to distinguish these influences, we carried out a systematic review and meta-analysis exploring the acute effect of antipsychotics on candidate cytokines plasma levels (IL-1 beta, IL-2, IL-6, IL-17, IFN-gamma, TNF-alpha) among drug-naive subjects with first episode psychosis. We searched main Electronic Databases, identifying eight studies meeting our inclusion criteria. Plasma cytokines values were used to estimate standardized mean differences. Heterogeneity across studies was evaluated using the I-2 index and controlled in relevant sensitivity analyses. IL-2 (p = 0.023) and IL-6 (p=0.012) levels showed a significant decrease after four weeks of antipsychotic treatment. Relevant sensitivity analysis confirmed these findings. IL-1 beta had high between-study heterogeneity. However, leaving out one study, a significant decrease after treatment was found. IL-6 and IL-2, and possibly IL-1 beta, could be considered state markers, decreasing after antipsychotic treatment, whilst TNF-alpha, IL-17, and IFN-gamma might be considered trait markers. Options for novel treatments in FEP, involving cytokine-modulating agents, should be further studied. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:122 / 128
页数:7
相关论文
共 52 条
[1]  
Androsova LV, 2007, ZH NEVROL PSIKHIATR, V107, P50
[2]  
[Anonymous], MOL PSYCHIAT
[3]  
[Anonymous], 1988, Statistical Power Analysis for the Behavioral Sciences
[4]   Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis [J].
Bak, Maarten ;
Fransen, Annemarie ;
Janssen, Jouke ;
van Os, Jim ;
Drukker, Marjan .
PLOS ONE, 2014, 9 (04)
[5]   The Role of Adipose Tissue and Adipokines in Obesity-Related Inflammatory Diseases [J].
Balistreri, Carmela Rita ;
Caruso, Calogero ;
Candore, Giuseppina .
MEDIATORS OF INFLAMMATION, 2010, 2010
[6]   Second-generation antipsychotics and adiponectin levels in schizophrenia: A comparative meta-analysis [J].
Bartoli, Francesco ;
Crocamo, Cristina ;
Clerici, Massimo ;
Carra, Giuseppe .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 (10) :1767-1774
[7]   Bipolar Disorder, Schizophrenia, and Metabolic Syndrome [J].
Bartoli, Francesco ;
Carra, Giuseppe ;
Crocamo, Cristina ;
Carretta, Daniele ;
Clerici, Massimo .
AMERICAN JOURNAL OF PSYCHIATRY, 2013, 170 (08) :927-928
[8]   Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome [J].
Beumer, Wouter ;
Drexhage, Roosmarijn C. ;
De Wit, Harm ;
Versnel, Marjan A. ;
Drexhage, Hemmo A. ;
Cohen, Dan .
PSYCHONEUROENDOCRINOLOGY, 2012, 37 (12) :1901-1911
[9]   Increase systemic levels of IL-23 as a possible constitutive marker in schizophrenia [J].
Borovcanin, Milica ;
Jovanovic, Ivan ;
Dejanovic, Slavica Djukic ;
Radosavljevic, Gordana ;
Arsenijevic, Nebojsa ;
Lukic, Miodrag L. .
PSYCHONEUROENDOCRINOLOGY, 2015, 56 :143-147
[10]   Antipsychotics can modulate the cytokine profile in schizophrenia: Attenuation of the type-2 inflammatory response [J].
Borovcanin, Milica ;
Jovanovic, Ivan ;
Radosavljevic, Gordana ;
Dejanovic, Slavica Djukic ;
Stefanovic, Vesna ;
Arsenijevic, Nebojsa ;
Lukic, Miodrag L. .
SCHIZOPHRENIA RESEARCH, 2013, 147 (01) :103-109